CYCC

Cyclacel Pharmaceuticals Inc (CYCC)

US
$ 0.48112.99%

Price Chart

Key Statistics

Market Cap
$ 27.16M
P/E Ratio
0.40
Revenue (TTM)
$ 14K
Volume
2.73M
52W High
$ 283.40
52W Low
$ 3.08
Dividend Yield
0.00%
Beta
0.04

Technicals

50-Day MA
13.0886
200-Day MA
77.3774
52 Week High
283.4045
52 Week Low
3.0801

About CYCC

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the U.

Employees
N/A
Headquarters
Kuala Lumpur, Malaysia
CEO
Dr. Sing Ee Wong

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
JELD
JELD-WEN Holding In...
$ 4.40
12.24
LVS
Las Vegas Sands Cor...
$ 47.36
8.87
CCS
Century Communities...
$ 61.22
8.70
KTB
Kontoor Brands Inc....
$ 71.65
8.61
BBWI
Bath & Body Works I...
$ 32.40
8.14

Top Losers

Symbol/Name
LTP
% Chg
ACHR
Archer Aviation Inc...
$ 9.97
-8.11
AMC
AMC Entertainment H...
$ 2.87
-7.42
OKLO
Oklo Inc.
$ 52.29
-6.58
QS
QuantumScape Corpor...
$ 6.29
-6.40
SE
Sea Limited America...
$ 150.49
-5.96